Fusen International Pharmaceutical Co., Limited

Yes. Fusen International Pharmaceutical Co., Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2026-05-11 (operating for under 1 year (Newly Incorporated)). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: May 2026).

The sole statutory identifier for Fusen International Pharmaceutical Co., Limited is its 8-digit Business Registration Number (BRN / Unique Business Identifier UBI): [80361779]. Pursuant to Phase 2 of the Unique Business Identifier (UBI) regime implemented by the Hong Kong Companies Registry on 27 December 2023, the 8-digit BRN issued by the Inland Revenue Department serves as the unified statutory identifier across all government departments for newly incorporated companies, and no separate legacy CRN is issued.

Under the Companies Ordinance (Cap. 622), Hong Kong corporations do not have a 'legal representative' role; executive authority vests in the Board of Directors (Section 643). Because Fusen International Pharmaceutical Co., Limited was incorporated within the past year (2026-05-11) and its first Annual Return (Form NAR1) is not yet due, its founding directors, company secretary, and initial share capital allotment are officially recorded in its Incorporation Form (Form NNC1), supplemented by any subsequent Return of Allotment (Form NSC1) or Notice of Change of Director (Form ND2A).

Pursuant to the Companies Ordinance (Cap. 622), statutory filings delivered by Fusen International Pharmaceutical Co., Limited—such as Incorporation Forms (Form NNC1), Annual Returns (Form NAR1 under Section 662), and notices of director or registered office changes (Form ND2A / Form NR1)—are maintained by the Hong Kong Companies Registry. Where online electronic image indexing is pending synchronization or involves early historical microfiche archives, manual statutory retrieval from the Companies Registry can be commissioned through our compliance team.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Chinese Medicine Regulatory Office (CMRO) (Licence No. PW-2026-00196); 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with the Hong Kong Judiciary public writs database and Official Receiver's Office (ORO) registers; no public civil action writs (HCA/DCCJ) or compulsory winding-up petitions (HCCW under Cap. 32) were found on current index records.

The statutory registered office of Fusen International Pharmaceutical Co., Limited on official record is situated at: [ROOM 02-03, 10/F, BLOCK F, SUPERLUCK INDUSTRIAL CENTRE, 57 SHA TSUI ROAD, TSUEN WAN, NEW TERRITORIES, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change. Under Section 3 of the Companies (Disclosure of Company Name and Liability Status) Regulation (Cap. 622B), the company must continuously display its registered name in legible characters at its registered office.

Under Section 127 of the Companies Ordinance (Cap. 622), Hong Kong has abolished the mandatory use of a metallic common seal; Fusen International Pharmaceutical Co., Limited (8-digit Unique Business Identifier (BRN / UBI): 80361779) may lawfully execute a commercial contract without a common seal by having the document signed on its behalf by its sole director (for a single-director company) or by two directors / one director and the company secretary, and under Cap. 622B Section 4 must state its registered legal name on all contracts, transaction instruments, and official websites. Because commercial rubber chops are not registered with the Hong Kong Government, counterparties must retrieve the latest Annual Return (Form NAR1), director change notices (Form ND2A), and Register of Charges filings (Form NM1 under Cap. 622 s.334) from the Companies Registry to verify authorized signatory directors and asset pledges.